Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Lower Cholesterol Cuts CV Events: Treat Stroke to Target Trial

News Conference News AHA 2019

Lower Cholesterol Cuts CV Events: Treat Stroke to Target Trial

November 18, 2019

Rivaroxaban Falls Flat in Antiphospholipid Antibody Syndrome

News Daily News

Rivaroxaban Falls Flat in Antiphospholipid Antibody Syndrome

October 15, 2019

‘Manageable’ Stroke Risk Seen With Electrical LAA Isolation

News Daily News

‘Manageable’ Stroke Risk Seen With Electrical LAA Isolation

August 19, 2019

Trial Points to Possible Benefit of Intensive BP-Lowering to Stave Off Recurrent Stroke

News Daily News

Trial Points to Possible Benefit of Intensive BP-Lowering to Stave Off Recurrent Stroke

July 29, 2019

Smoking More Strongly Linked to Long-term Risks of PAD Than to Other Types of CVD

News Daily News

Smoking More Strongly Linked to Long-term Risks of PAD Than to Other Types of CVD

July 24, 2019

TCAR Use Growing for Carotid Stenosis as Positive Data Continue to Accumulate

News Daily News

TCAR Use Growing for Carotid Stenosis as Positive Data Continue to Accumulate

June 17, 2019

Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry

News Conference News EuroPCR 2019

Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry

May 31, 2019

Rivaroxaban Cuts Major Stroke Risk in COMMANDER HF Post Hoc Analysis

News Conference News ESC Heart Failure 2019

Rivaroxaban Cuts Major Stroke Risk in COMMANDER HF Post Hoc Analysis

May 26, 2019

Ultrasound-Enhanced Thrombolysis No Help in Stroke: CLOTBUST-ER

News Daily News

Ultrasound-Enhanced Thrombolysis No Help in Stroke: CLOTBUST-ER

April 04, 2019

When Is It Time to Abandon Thrombectomy for Acute Stroke? New Clues

News Daily News

When Is It Time to Abandon Thrombectomy for Acute Stroke? New Clues

February 25, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.